Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
Patients should check their blood glucose during symptomatic episodes, especially if taking insulin or sulfonylureas alongside tirzepatide, as hypoglycemia can cause similar symptoms
While many people tolerate semaglutide well and see significant benefits, its important to weigh these potential side effects with your healthcare provider to determine if its the right fit for your health goals
No questions are too small, I get all the detail I want, and texts are answered quickly and thoughtfully. These guys make everything super easy
Medicare beneficiaries who are already receiving coverage from their Part D plan for a GLP-1 for a Medicare-covered use, such as type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea, will continue to access the drug through their Part D plan and not through the Medicare GLP-1 Bridge, which will only provide coverage of GLP-1s when used for obesity
